Most people are familiar with CoQ10 products. They are mostly being promoted for their benefits on the heart. Our bodies use two forms: Ubiquinone and Ubiquinol.
CoQ10 provides the energy for vital cellular functions and is known to act as an antioxidant. In this study they examined the clinical effects of supplementation of the reduced form of CoQ10, ubiquinol, in addition to conventional glucose-lowering agents in patients with type 2 diabetes. Nine subjects (3 males and 6 females) with type 2 diabetes and receiving conventional medication were recruited. The subjects were assigned to receive an oral dose of 200 mg ubiquinol daily for 12 weeks. The effect of ubiquinol on blood pressure, lipid profile, glycemic control, oxidative stress, and inflammation were examined before and after ubiquinol supplementation. In addition, five healthy volunteers were also assigned to receive an oral dose of 200 mg ubiquinol daily for 4 weeks to examine the effects of ubiquinol on insulin secretion. In patients with diabetes, there were no differences with respect to blood pressure, lipid profile, oxidative stress marker, and inflammatory markers. However, there were significant improvements in glycosylated hemoglobin (HbA1C). The results of this study are consistent with the suggestion that the supplementation of ubiquinol in subjects with type 2 diabetes, in addition to conventional medications, improves glycemic control by improving insulin secretion without any adverse effects.
References
The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: An open label pilot study. Mezawa M, Takemoto M, Onishi S, Ishibashi R, Ishikawa T, Yamaga M, Fujimoto M, Okabe E, He P, Kobayashi K, Yokote K.
Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-Ku, Chiba-Shi, Chiba 260-8670, Japan; Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Chiba University Hospital, 1-8-1 Inohana, Chuo-Ku, Chiba-Shi, Chiba 260-8670, Japan.
Sharing is caring!
Vitamin D deficiency and autoimmune thyroid disease
New research out of South Korea suggests there is an association between vitamin D deficiency and autoimmune thyroid…
Proton pump inhibitors reduces microbial diversity
Before taking your daily antacid, you might consider how it is affecting the trillions of bugs living in your gut. A…
Low vitamin D levels in patients with autoimmune arthritis
Spondyloarthritis is any arthritis (inflammation) of the spinal column. Ankylosing spondylitis (AS) is a specific…
Polycystic ovary syndrome: Lifestyle management combined with metformin
A new review just published in the journal Human Reproduction Update found that women with polycystic ovary syndrome…
New study investigates the effects of vitamin D supplementation on depression
Depression is a major cause of disease burden worldwide which affects approximately 350 million people. Although…
New study shows low commensal bacteria in multiple sclerosis patients
According to a new study published earlier this week in Scientific Reports, researchers are saying low amounts of…
New review demonstrates the benefits of blueberry supplementation in patients with metabolic syndrome
Metabolic syndrome and insulin resistance are a significant health care problem in the United States. Type 2…
Chemical exposure linked to diabetes and obesity epidemic
According to a statement issued 3 days ago by the Endocrine Society, their summary links endocrine-disrupting chemical…
Vitamin D and autoimmune conditions: The latest research
Autoimmune disorders occur when the body’s immune system is tricked into thinking that self is foreign and starts…